---
document_datetime: 2023-09-21 18:47:42
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/myclausen-epar-all-authorised-presentations_en.pdf
document_name: myclausen-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8927878
conversion_datetime: 2025-12-17 09:18:49.890576
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical form   | Route of administration   | Immediate Packaging   | Pack size    |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|--------------|
| EU/1/10/647/001  | Myclausen         | 500 mg     | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 50 tablets   |
| EU/1/10/647/002  | Myclausen         | 500 mg     | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 150 tablets  |
| EU/1/10/647/003  | Myclausen         | 250 mg     | Capsule, hard         | Oral use                  | blister (PVC/alu)     | 100 capsules |
| EU/1/10/647/004  | Myclausen         | 250 mg     | Capsule, hard         | Oral use                  | blister (PVC/alu)     | 300 capsules |